Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology

J Allergy Clin Immunol Pract. 2019 Feb;7(2):721-723.e9. doi: 10.1016/j.jaip.2018.12.009. Epub 2018 Dec 14.

Authors

Bradley E Chipps¹, Christina E Ciaccio², Karin Rosén³, Tmirah Haselkorn⁴, Ellen Zigmont³, Thomas B Casale⁵

Affiliations

¹ Capital Allergy & Respiratory Disease Center, Sacramento, Calif. Electronic address: [email protected].
² The University of Chicago Medicine, Chicago, Ill.
³ Aimmune Therapeutics, Brisbane, Calif.
⁴ EpiMetrix, Inc, Los Altos, Calif.
⁵ Division of Allergy and Immunology, University of South Florida, Tampa, Fla.

PMID: 30557711
DOI: 10.1016/j.jaip.2018.12.009

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Allergens / immunology
Allergists / statistics & numerical data*
Arachis / immunology
Desensitization, Immunologic / methods*
Health Knowledge, Attitudes, Practice*
Humans
Maximum Tolerated Dose
Peanut Hypersensitivity / epidemiology
Peanut Hypersensitivity / immunology
Peanut Hypersensitivity / therapy*
Practice Guidelines as Topic
Terminology as Topic
United States / epidemiology

Substances

Allergens